Results 31 to 40 of about 126,231 (300)

Analysis of Therapeutic Decisions for Infantile Hemangiomas: A Prospective Study Comparing the Hemangioma Severity Scale with the Infantile Hemangioma Referral Score

open access: yesChildren, 2022
Background: In view of the high incidence of infantile hemangioma (IH) in infants and young children, a comprehensive and reasonable evaluation scale for referral is urgently needed. This study compared the influence of the Hemangioma Severity Scale (HSS)
Tong Qiu   +4 more
doaj   +1 more source

The Role of Topical Timolol in the Treatment of Infantile Hemangiomas: A Systematic Review and Meta-analysis. [PDF]

open access: yes, 2017
To date the efficacy and safety of topical timolol in the treatment of infantile hemangioma has not been reviewed and analysed systematically. We collated all published data on the efficacy and safety of topical timolol in the treatment of infantile ...
Boyce, Aaron   +5 more
core   +3 more sources

Integrated WGCNA and PPI Network to Screen Hub Genes Signatures for Infantile Hemangioma

open access: yesFrontiers in Genetics, 2021
Background Infantile hemangioma (IH) is characterized by proliferation and regression. Methods Based on the GSE127487 dataset, the differentially expressed genes (DEGs) between 6, 12, or 24 months and normal samples were screened, respectively.
Miao Xu   +3 more
semanticscholar   +1 more source

Biology of Infantile Hemangioma [PDF]

open access: yesFrontiers in Surgery, 2014
Infantile hemangioma (IH), the most common tumor of infancy, is characterized by an initial proliferation during infancy followed by spontaneous involution over the next 5-10 years, often leaving a fibro-fatty residuum. IH is traditionally considered a tumor of the microvasculature.
Tinte eItinteang   +4 more
openaire   +4 more sources

Results of Infantile Hemangioma Laser Therapy in Children with Persistent Residual Signs after Systemic Propranolol Therapy: Clinical Cases

open access: yesВопросы современной педиатрии, 2021
Background. Infantile hemangiomas are revealed in 1-3% of newborns and 10-12% of infants. There are only anecdotal reports on the laser therapy efficacy in this pathology management.
Tatyana S. Belysheva   +6 more
doaj   +1 more source

Propranolol as first-line treatment for life-threatening diffuse infantile hepatic hemangioma: a case report [PDF]

open access: yes, 2017
[No abstract ...
Clerico, Anna   +6 more
core   +1 more source

Infantile hemangioma presenting as colocolic intussusception in an infant case report with review of pathologic lead points [PDF]

open access: yes, 2018
Infantile hemangioma (IH) is one of the most common vascular anomalies of early childhood and is usually recognized in the first few weeks to months of life as a solitary cutaneous lesion.
Dehner, Louis P.   +3 more
core   +2 more sources

Efficacy of Intravenous Propranolol for Life-threatening Diffuse Neonatal Hemangiomatosis [PDF]

open access: yes, 2022
Oral propranolol is recommended as the first-line agent for infantile hemangioma requiring systemic treatment. Life-threatening complications such as obstructive infantile hemangioma of the airway or infantile hepatic hemangioma associated with high ...
Ishikawa, Takamichi   +2 more
core   +1 more source

Clinical Features, Prognostic Factors, and Treatment Interventions for Ulceration in Patients With Infantile Hemangioma.

open access: yesJAMA dermatology, 2021
Importance Ulceration is a common complication of infantile hemangioma (IH), which leads to substantial morbidity. Ulceration in IH has not been systematically studied since the advent of β-blocker therapy for IH.
Esteban Fernández Faith   +16 more
semanticscholar   +1 more source

Propranolol for Infantile Hemangiomas

open access: yesPediatric Dermatology, 2011
Abstract:  Propranolol has been used successfully in a limited number of children with infantile hemangiomas. This multicenter retrospective study describes the efficacy and adverse effects of propranolol in infantile hemangioma. Seventy‐one infants with infantile hemangiomas were treated with oral propranolol, 1 mg/kg/12 hours, for at least 12 weeks ...
Antonio Baño   +11 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy